Table Of Content

EDITORIAL INDEX JANUARY—DECEMBER 1998, VOLUME 43 Boike GM, Dobbins B Dinsmoor MJ Hillard PA IDENTIFICATION CODES New equipment for operative laparoscopy. 43-52, Ophthalmia neonatorum. 25-28, Feb, oa Legacy of Roe v Wade: protecting women’s health bb— Back to Basics Apr 15, oa Dinsmoor MJ: see Mead PB through legal abortion. 33-44, May 15, oa Borenstein DG, Deyo RA, Marcus NJ Dobbins B: see Boike GM Hirshberg SJ: see Lipshultz L! cd— Clinical Dialogue Low-tech approach to low-back pain. 80-98, Oct, oa Driguez PC: see de Ligniéres B Hobei CJ co— Controversies in Ob/Gyn Bradshaw KD: see Speroff L Duff P: see Clark P Routine antenatal laboratory tests and specific Branch W: see Scott JR Dunaif A: see Speroff L screening tests. 15-22, Feb, 0a ed— Editorial Bristow RE, Berek JS Dunton CJ: see Feld R Holmes MM emotau——— EMOqraiulgapilrn aacTlt iimAceret icle SBBEufuurfrseFgghciete cbsar, Tl o L oRa fAm :ap rnsoaeggee estmMieonnns tk onB oJfe sdtyrsoggeenrimsi nocmarad.i opr9o8t-ec1t1i9v,e ESEEtdddeddd1miii4 e1ee-mmmc1eaaal5lnnn5s , : KKKAAAWJ:u,h l a,tsS et oeao tnhSeet oJonLbe,s teBJteLrr ikcoiawni tzn eeRdLs to know CHPlroieinMmnizacaagayttlr,ae e lrv mn0eaaad lni Waa,ggbn eloSomsoaedinn:st t RwWoii,lft l hG raavtfpiheeent a li pAn rMcao,edml olilsHs eaesh ecnnerbn ietSs c. hf eudl6 f2il-fl7re8od,m? psASppyqer——c i1a5l —PSaiy stmshpuooelssTo:eig cyu hmn Qouliozg y BTCCCauaaaksrrrei1rtfiin2 fegg9gerBcnn, tA aasa:J.nnO Ec r,tse,CC e1s ::e8Cu - ola2ssatKr6ee sis.ee- n oogrnPPSi aoeetLlnSiplAt A ae S(dcs ku papAlp)pE,r oaoac h to infertility. 100- FEREeolltlklaooeealav r s at reosicJfoah Cnno, rg eCecKaa,nansi rcKscieo era.esn bn soiwmB1geelY0 n: 1 Jt-, 1 t1Th1lre,ua s pbsaoAertulotglso, cm Joo,pal y iBn ue.l li n5 J3m -6a9n,a giDencg, HSHcuurepo11eplv70eaes87nrr-m-iit1a1an n83ng 82J ,,:c KyasnoMSNecue,eoer pv r ,,:HH puuooapehaatp loieewsnr mttats on J c,foo KlFrlM ieo cirtn ihcefara imitJle yd hbirsteoarsyt daatnad Carson SA: see Buster JE Emergency contraception. Authors’ reply. 156-157 Im DD, Rosenshein NB May 15— 25th Anniversary Issue CKaarrysootynp esS.A 41-45, Jan, bb EmaFenbs, eSt: see Kahn JA Use7 1o-f8 7u,l trMaasr,o ni0c a surgical aspiration in gynecology. Pet) CMietfoasliso, RmCe,i oWsiasl,t era ndT Sn,o nHdaisajcuknc tSioMn,. Sp47e-i5c1h,i ngMaerr, JbPb EErnkskroulda KRE: see Archer DF ICnoautnis eMli ng for fetal anomalies. 15-19, Oct, oa Abramovici D, Mattar F, Sibai BM MCTihwseesnzet dy R-Afa biovret iony.e arAsu thoorf s’c erseaplrye. an1 71d,e liAvperr,y .e t 87-97 SEParounsnetasp ta rvtsJ.u Mm, h oetM nedtouabmd.e t r1iP7tB3i, s . Mar3,3 -3e8t, Jan, 0a IJMovifesfyse e dP A:a bsoretei onC.l ar1k7 1L,R Apr, et Conservative management of severe preeclampsia May 15, oa Eschenbach DA Jonas WB: see Chez RA 80-105, May, oa Chez RA, B-Lynch C Preventing and managing incisional surgical site Kahn JA, Emans S Alger LS B-Lynch suture for control of massive postpartum infections. 69-85, Sep, oa Gynecologic examination of the prepubertal girl Acute respiratory distress syndrome. 25-33, Nov, oa hemorrhage. 93-98, Aug, cd Eschenbach DA: see Mead PB 71-90, Jul, oa Amstey MS Chez RA, Bofili JA, Morrison JC Ettinger B: see Lobo RA Karlan BY: see Elkas JC Lyme disease in pregnancy. 31-39, Jul, oa Performing vacuum-assisted vaginal delivery. 61-67 Feld R, Dunton CJ Kaunitz AM, Lentz G, Sherwin B, Kingsberg S Angioli R, Barreau G Nov, cd Percutaneous abscess drainage in gynecology Sexuality after menopause. 138-159, Apr, sy Interceed use and adhesion prevention in gynecol- Chez RA, Jonas WB 66-74, Apr, oa Kimbro LT: see Hagerman RJ ogy. 96-102, Nov, oa One kind of medicine or many? The view from NIH Finan MA, Kline RC King LA, Carr BA Archer DF 123-145, Feb, cd Controversies in the management of stage 1B Phytoestrogens: fact or fiction. 49-66, Sep, 0a Foreword: Osteoporosis: Assessment, diagnosis Chez RA, Parsons AK cervical cancer. 77-100, Apr, oa Kleerekoper M treatment, and prevention. 3, Apr (suppl), ed Performing saline infusion sonography. 110-122 Current management of endometrial cancer. 85-99 Biochemical markers of bone remodeling in day-to- Progesterone: Pharmacokinetics and physiologic Sep, cd Dec, oa day patient care. 35-46, Nov, oa effects. 4-9, Sep (suppl), oa Chez RA, Stark M Fiorica J: see Huelsman KM Kleerekoper M: see Archer DF Archer DF: see Speroff L Misgav Ladach method of cesarean section. 81-88 Fiorica JV, Schorr SJ, Sickles EA Kleerekoper M: see Speroff L Archer DF, Clisham PR, Ensrud KE, Kleerekoper Jun, cd Benign breast disorders: first rule out cancer Klein J, Klobutcher JA, Saldanha R, Raviele KM M, Nunley WC Jr Clark LR, Cohall AT, Joffe A 154-172, Mar, oa Emergency contraception. 156-157, Feb, et Osteoporosis: Assessment, diagnosis, treatment, and Beyond the birds and the bees: talking to teens about Fox HE: see Wallach EE Kline RC: see Finan MA prevention. 4-26, Apr (suppl), sy sex. 35-64, Apr, 0a Frank TS Klobutcher JA: see Klein J Arendt EA, Saint-Phard D, Shangold MM Ciark P, Duff P Identifying women with inherited risk for ovarian Koenig J: see Ellertson C AAcvteiOrvceett , tweoo a mHaEn : special health concerns. 131-140 PCyleilsohneapmh riPtRi:s siene prAergcnhaencry . DF 31-42, Mar, oa GAmanbcibaonetci ecrS : Gf lwuihdo inadnidc esw hoyf? ma2t7u-r5i0ty,. D1e5c-,2 0o,a Sep, oa KPuobvtiaeccr m bSocRnu,re e Crsfuourbi ukSrUseIth?ha rna5kl2 -7Ss6Ht,a biFleibz,a tiooan sling: a long- Progress in gynecologic oncology. 125-146, May 15, oa Cohall AT: see Clark LR Garcia J: see Wallach EE Larsen JW Jr Avioli LV: see Speroff L Collea JV: see Macedonia CR Gass ML Group B streptococcal infections in pregnancy. Azziz R: see Speroff L Collins D Myth of calcium. Author's reply. 174, Mar, et 21-26, Oct, 0a Bachmann GA: see Lobo RA Malpractice. 124-127, May, mu Gavin AM: see Holzgreve W Larsen JW Jr: see Mead PB Bachmann GA: see Speroff L Malpractice. 146-149, Jun, mu Genant HK: see Njeh CF Leach GE, Haab F Baker CJ: see Mead PB Malpractice. 164-167, Jul, mu Gibbs RS Impact of female pelvic anatomy on stress urinary Baker JG, Rosenthal SL Malpractice. 168-172, Aug, mu Antibiotic use for preventing preterm birth. 26-32, incontinence. 45-59, Oct, oa Adolescents’ risk of STD acquisition: developmental Malpractice. 200-204, Sep, mu May, 0a Lentz G: see Kaunitz AM considerations. 79-91, Aug, 0a Malpractice. 156-159, Oct, mu Giudice LC: see Speroff L Levine MA: see Salvatori R BMaallplraadc tiRc e. 147-151, Jan, mu MMaallpprraaccttiiccee.. 113380--114325,, NDoevc,, mmuu GGoollddsetnebienr gM AR L: see D’Alton ME LTirnedathmeeinmt SRo ptions for recurrent endometriosis. MBaalrpbriaecrtii ceR. L 146-149, Feb, mu CCrouwiakns haBDn:k sSeHe: Ssteoev alKlo vTaGc SR HepaSteipt,i s0 a B vaccination for adolescents. 153-161, Lin3d4h-4e1i,m erOc t,M Bo:a see Davison JM Seven steps to the effective treatment of osteoporo- Cunningham F Gordon CL: see Njeh CF Lipshultz LI, Hirshberg SJ sis in your practice. 30-50, Feb, oa Sepsis syndromes. 13-16, Dec, oa Gradishar WJ: see Bines J Sperm-function tests. 87-108, Sep, oa Barreau G: see Angioii R D’Alton ME: see Malone FD Haab F: see Leach GE Lobo RA BBBBeeeerrrregkkkaoo wwiiJSttSL::zz ssRReeLLee:: BSssrpeeieeesr otDEfo’dfwAd liLtReo Emn anM E KA DUDl’’tAArrlleattvsoooolnnuu tnidMMo nEE., in B6o7eb-sr8tke4ot,wr iicMtsza ya RnL1d5, , gGyoonae lcdoelnogbye:r g anR L,i maging HHPHuaaaeaggrecperkerr maWSlaD Mn: m asRstJeit,ei sK.C iefm2ab7lr-oo3 3,RL CT ,Ap rT,a y0lao r AK FFoorrteeehfwwefoorercardtpd:sy: ,. Ca3unN,rd ar Mtesnuaatryf ae tlcy( l.si unppip3crl,ao)l ,g S eeuespsdt e es( rsuoopnfpel )l:,o we-Mdd eosceh aensitsrmosge,n Berkowitz RL: see Stone JL Wapner RJ Fragile X syndrome: a common cause of mental Bines J, Gradishar WJ Prematurity in multifetal pregnancy: can we reduce retardation and premature menopause. 47-70 Caring for the breast cancer survivor. 37-56, May, oa the risk? 112-140, Aug, sy Jan, 0a Reprints of all articles are available. Birge SJ: see Speroff L Davison JM, Lindheimer MB Hans D: see Njeh CF For single copies, call Customer B-Lynch C: see Chez RA Renal disease. 13-21, Nov, 0a Helmbrecht GD Service, 800-432-4570, and specify Bobrowski RA: see Mason BA de Ligniéres B, Driguez PC Syncope. 15-25, Jun, oa the article title and publication date. Bofill JA: see Chez RA Long-term experience with oral micronized proges- Henderson VW: see Speroff L For multiple copies, call Lisa Lucas, Bofill JA, Martin JN Jr, Morrison JC terone and effects on the endometrium. 10-17 Hill GB 201-358-7446. Mississippi operative vaginal delivery trial: Lessons Sep (suppl), oa Techniques for isolating pelvic bacterial pathogens. learned. 60-79, Oct, 0a Deyo RA: see Borenstein DG 49-56, Nov, 0a DECEMBER 1998 = CONTEMPORARY OB/GYN 105 EDITORIAL INDEX—IDENTIFICATION CODES bb— Back to Basics ed— Editorial Original Article Special issues: Clinical Dialogue et— Equal Time pq— Pathology Quiz April 15— Technology co— Controversies in Ob/Gyn mu— Malpractice sy— Symposium May 15— 25th Anniversary Issue Lobo RA, Bachmann GA, Ettinger B, Santoro NF, 0 e front lines, in ob-gyn and on the Yangtze Foreword: Mood, cognition, and dementia: Effects of Shoupe D 8-13, Sep, ed postmenopausal hormone therapy. 3, Feb (suppl), ed SUBJECTS ares cal uses jose estrogen therapy Redlining comes to managed care. 8-11, Nov, ed Foreword: Your menopausal patient: Individualizing -26, May (supp! There's still no place like home. 8-11, Aug, ed management. 3, Jun (suppl), ed uaaaae CJ UK medical training bottieneck. 8-10, May, ed Foreword: Postmenopausal hormone therapy ABNORMALITIES Autoimmune diseas an, 0a Queenan JT, Queenan CN Treatment choices for medical conditions. 3, Nov Assessment of gestational age. 15-28, Mar, oa Macedonia *,C ollesN , _—— JH China: land of contrast, land of change. 36-46, Aug, (suppl), ed Baby born with spina bifida. 149, Jun, mu ind gynecology 0a Quarter century of contraception: remarkable Counseling for fetal anomalies. 15-19, Oct, oa 97-111 ae 15, 0¢ Rabin DS advances, increasing success. 13-28, May 15, 0a Echogenic intracardiac focus. 73-78, Jun, 0a Malone FD, D’Alton ME Understanding why women won't take HRT Speroff L, Archer DF, Avioli LV, Bradshaw KD, Fertility over 35: Improving the odds. 106-118, Fetal nuchal fold translucer 133-141, Jan, 0a Moghissi KS May, sy Mar, oa Reedy M, Uy K, Thompson E, Rayburn WL Your ae patient: Individualizing manage- Fetal echogenic bowei: the bottom line. 53-69 Marcus NJ: see Borenstein DG Laparoscopy during pregnancy: a safe alternative to ment. 4-26, Jun (suppl), sy Dec, oa Martin Jr JN: see Bofill JA laparotomy? 75-91, Apr 15, oa Speroff L, Azziz R, Dunaif A, Giudice LC, Fetal nuchal fold translucency screening. 117-131 Mason BA, Bobrowski RA Richart RM Sobel BE Mar, 0a Cardiac disease. 15-26, Aug, 0a Cervical neoplasia: past, present, and future. 117 Diagnosis and management of polycystic ovary syn- First-trimester amniocentesis: weighing the evi- Mattar F: -¢ Abramovici D 132, May 15, 0a drome. 4-26, Jul (suppl), sy dence. 128-138, Jul, oa MMIMneeefaaaee1cdddm0t 7 ei-orPPP1ugB1BBsi:4 , n, gdsEi esseMec aphEyaer nneb15s,a tc 1he nJ0 OsaM D -D gAy arn d far omc ha1n9g7i3n g to f1o9c9us8 RRDRRRiiaoootccsssehkee eaennrrnrtsttawhph eaae:VRlk iIM s,n:o Sf WLfiN2s:i:eB ec e:esms -eeabePesna i esrenBWe o adagi kl CmelsE MraoCl D cu DhtJi Go nEsE. 133-153, Mar, oa SSPppoeesMfrrtoioomrs ffehmffnee oldpLlLia, ,cu aBDBsleRaa r lcc gJhoarnmh,d oi aStSrniLtmon,oan snmB.ep iG frAeg4,th-er e2 Kr6SalM,pJe Jy,e:, N r oHevSTek urnole(dplsaeuietprvmrpase lnn)oM ,tn ,J s McyVh Woi,c es FFKarorauJ8ygrraoie9-ntlt-,yeca1 p rh1ed0a2sXaa,m.t biseoyJn4ran 1n d,-r a4von5i0md,eae w :;J p arnee,axm pabcetbcou trmaemt oionmn esn ocpaaaunusdes el.io mfi t4ma7tei-no7tn0as,l Vaginitis 1998: Upcate and guidelines 116-132 Saint-Phard D: see Arendt EA Sherwin BB Laparoscopy during pregnancy: a safe alternative to MeaJadn, PcBd, Larsen JW Jr, Dinsmoor MJ, SSaallvdaatnohria RR,: Lseeve inKel eiMnA J Moomde,n opcaougsnailti ohn,o rmaonnde dtheemreanptyi.a :4 -24E,f feFcetbs (soupfp l)p,o sts-y Lymlea padriosteaosmey ? in 75p-r9eg1n,a nAcpy.r 153,1 -03a9 , Jul, 0a Gilstrap tli LC Bisphosphonates for treating and preventing Spong CY Prematurity in multifetal pregnancy: can we reduce Preventing GBS transmission to neonates 53-69 osteoporosis. 105-120, Apr, 0a Antepartum fetal monitoring: when, what, and how the risk? 112-140, Aug, sy Mar, sy Sanders JH: see Macedonia CR 36-45, Sep, oa Prenatal diagnosis with fetal cells enriched from Mead PB, Schuchat A, Baker CJ Sant R: see Holzgreve W Stampfer MJ: see Speroff L maternal blood: Will the promise be fulfilled? GBS update: a progress report. 7 Sant GR Stark M: see Chez RA 178-188, Sep, oa Mishell DR Jr: see Speroff L Interstitial cystitis—a urogynecologic perspective Stone JL: see Eddleman KA Sauna vs. hot tub. 173, Mar, et Moghissi KS: see Speroff L 119-130, Jun, oa Stone JL, Eddleman KA, Berkowitz RL Ultrasound fetal survey. 15-28, Jul, 0a Monk BJ, Gurger RA Santoro NF: see Lobo RA Echogenic intracardiac focus. 73-78, Jun, 0a Wrongful birth of infant with gastroschisis. 135 New therapie ondyioma in women Sanz LE Stovall TG, Cowan BD Dec, mu meus JC: see Bofill JA My vaagpipnralo acprho latpos e.s urg7i2c-a8l7 , coJrarne,c t0iao n of total utero- Is mpertehgontarnecxya?t e 14o2pt-i1m6a0l, fiOrcstt,- licnoe therapy for ectopic ABORTION Morrison JC: see Chez RA Sutures in gynecologic surgery. 57-72, Apr 15, oa Beyond the birds and the bees: talking to teens Muto MG: see Shepherd JE Schorr SJ: see Fiorica JV Stringer NH about sex. 35-64, Apr, oa telson RL hy it belongs in gyne: SSccihaullcih aAtR A: see Mead PB Lapnairquoes.c op6i1c- 71,su tuJruinn,g : oa a fast and easy new tech- ChinAau:g , l0aa nd of contrast, land of change. 36-46, NjeChO IOCgFI,C Gporracdtoicne . CL4,9 -H7 ans0, F uerst, Genant HK SNcaoutste a JRa,n dB rvaonmicthin g.W 13-16, May, 0a STualdliirv aYn JM: see Speroff L Confotrewmarpdo.r ar1y0 -12O,B /GMYaNy: 15,\ ooekdi ng back and looking New generation of bone densitometers. 15-40 Immunology of early pregnancy loss. 40-56, Jun, oa Ten years of laser-assisted gamete and embryo Counseling for fetal anomalies. 15-19, Oct, oa Apr 15, 0a Seeds JW manipulation. 126-150, Sep, oa Emergency contraception. 156-157, Feb, et Nunley WC Jr: see Archer DF Ultrasound fetal survey. 15-28, Jul, oa Taylor AK: see Hagerman RJ Emergency contraception. Authorsi reply. 156-157, Parsons AK:s ee Chez RA Seiden MV: see Sharpless NE Thompson E: see Reedy M Feb, et Pati S: seeP ollack AE Seifer DB Toby T: see Wallach EE First-trimester amniocentesis: weighing the evi- Pati S, Carignan C, Pollack AE Is methotrexate optimal first-line therapy for ectopic Trimble EL dence. 128-138, Jul, oa What's new with female sterilization: an update pregnancy? 142-160, Oct, co ERT for endometrial cancer survivors? 160-164 Informed consent. 146-149, Jun, mu 91-117, Jun, oa Sever JL Apr, oa Legacy of Roe v Wade: protecting womenis health Pheips JY: see Viahos N Toxoplasmosis in pregnancy. 21-24, Dec, oa Trussell J: see Ellertson C through legal abortion. 33-44, May, oa PPiPCeierlnrloJk iuglecm, yr oectn 0omoan p a uJsVe, :nW eoo eRdassMJio nng StAh e transition. 93-114 SSSKlehhiwaaAnernuelaggfl,roe all tC0deaA Fr :l' M sMs e:e s yVsneidea rhoAomrsee :n Nd t aEn A update. 142-158, VUHeyul m1tKa4:mn5 a,es ne eJ uaLnRp, ep reoodaa yc hM to neonatal circumcision. 135- MPSreiepstmsshaieetsd u rrsiaiysbtknoy?rd trio1iomn1n e.2 .m- u1l41t701i1f3,,e- t 1aA6Al,up r g,,p D reeesctg,y n anocay : can we reduce ca lagia ar poid uterine mass Sharpless NE, Seiden MV Viahos N, Sewell CA, Phelps JY ABORTION, SPONTANEOUS Diagnosis: High netrial stromal sarco- Advanced ovarian cancer: recent progress and Gonadotropin-releasing hormone analogs (agonists Fertility over 35: Improving the odds. 106-118, ma. 70-81 current challenges. 123-137, Apr, oa and antagonists). 82-95, Nov, oa May, sy Platt LD Shepherd JE, Muto MG Walker CK Immunology of early pregnancy loss. 40-56, Jun, oa Assessment of g nal age 15-28, Mar, 0a Testing for genetic susceptibility to ovarian and Trichomoniasis. 23-35, Sep, 0a Laparoscopy during pregnancy: a safe alternative to Pollack AE: see Pati S breast cancer. 88-114, Mar, oa Wallach EE laparotomy? 75-91, Apr 15, oa Pollack AE, Carignan C, Pati S Sherwin B: see Kaunitz AM Then and now—the explosion of reproductive What’s new with male sterilization an update Sherwin BB: see Speroff L options. 47-59, May 15, oa ABSCESS 41-67, Jul, 0a Shoupe D: see Lobo RA Wallach EE, Fox HE, Toby T, Faden R Percutaneous abscess drainage in gynecology Queenan CN: see Queenan JT Sibai BM: see Abramovici D Managed care and ethics. 162-176, Sep, sy 66-74, Apr, 0a Queenan JT Sickles EA: see Fiorica JV Wallach EE, Garcia J, Rosenwaks Z, Seifer DB Puerperal mastitis. 27-33, Apr, 0a Appreciation, admiration, and anticipation. 8-11 Simpson J Fertility over 35: Improving the odds. 106-118, Feb, ed Genetic revolution. 99-104, May 15, 0a May, sy ABSORPTIOMETRY Better loving through chemistry? 8-11, Jun, ed Simpson LL Walter TS: see Cefalo RC New generation of bone densitometers. 15-40, Contemporary OB/GYN: \ooking back and looking Four-chamber view; expectations and limitations. Watts DH Apr 15, 0a forward. 10-12, May1 5, ed 89-112, Jan, 0a Hepatitis C, D, and E in pregnancy. 29-38, Jun, oa European tobacco ‘smoke screen’. 12-15, Apr, ed Sloan D Whitney JL ADENOCARCINOMA Freewheeling managed-care enterprise. 8-11 Myth of calcium. 173-174, Mar, et Talking about sex: an interview with Gloria Feldt. Controversies in the management of stage 1B cervi- Dec, ed Sobel BE: see Speroff L 52-58, Apr, oa cal cancer. 77-100, Apr, oa Genetic amnioc esis. 16-24, Apr, oa Soderstrom RM Wiemann CM: see Rickert VI Human potential a global perspective. 10-13, Beyond ‘band aid’ surgery. 12, Apr 15, ed Wilson R ADHESIONS Jul, ed Speroff L First-trimester amniocentesis: weighing the evidence. Interceed use and adhesion prevention in gynecolo- Ob-gyn in the year 2025. 8-11, Mar, ed Foreword: Diagnosis and management of polycystic 128-138, Jul, oa gy. 96-102, Nov, oa Of epidurals and patient equality. 10-13, Oct, ed ovary syndrome. 3, Jul (suppl), ed Woodson SA: see Pinkerton JV Missed abortion. Authorsi replies. 171, Apr, et 106 CONTEMPORARY OB/GYN = DECEMBER 1998 EDITORIAL INDEX—IDENTIFICATION CODES bb— Back to Basics ed— Editorial Original Article Special issues: cd— Clinical Dialogue et— Equal Time Pathology Quiz April 15— Technology co— Controversies in Ob/Gyn mu— Malpractice Symposium May 15— 25th Anniversary Issue | Negligent removal of bowel adhesions. 142, Nov, mu AMNIOTIC FLUID ANTIBODIES BACTERIURIA Negligent surgery for uterine adhesions. 141, Amniotic fluid indices of maturity. 15-20, Sep, oa Immunology of early pregnancy loss. 40-56, Jun, 0a Antibiotic use for preventing preterm birth. 26-32 Nov, mu Techniques for isolating pelvic bacterial pathogens Prenatal diagnosis with fetal cells enriched from May, oa Role of reassessment laparoscopy in managing ovar- 49-56, Nov, 0a maternal blood: Will the promise be fulfilled? 178- Pyelonephritis in pregnancy. 31-42, Mar, oa ian cancer. 101-111, Aug, oa 188, Sep, oa ADOLESCENCE ANDROGENS Sperm-function tests. 87-108, Sep, oa BATHS, FINNISH Adolescents’ risk of STD acquisition: developmental Gonadotropin-releasing hormone analogs (agonists Sauna vs. hot tub. 173, Mar, et considerations. 79-91, Aug, 0a and antagonists). 82-95, Nov, oa ANTICONVULSANTS Beyond the birds and the bees: talking to teens Syncope. 15-25, Jun, 0a BEHAVIORAL THERAPY about sex. 35-64, Apr, oa ANEMIA One kind of medicine or many? The view from NIH Clinical management of rape in adolescents. 62-78, Pyelonephritis in pregnancy. 31-42, Mar, oa ANTIDEPRESSANTS 123-145, Feb, cd May, oa Interstitial cystitis—a urogynecologic perspective DGaytnee croalpoe:g ico ffiecxea-mbiansaetd iosno lutoifo nst.h e 1p3r3e-p1u5b3e,r taMalr , gioral ANESTHESIA 119-130, Jun, oa BIOCHEMISTRY Hepa7t1i-t9i0s, BJu lv, acocai nation for adolescents. 153-161, CCaorndsiearcv atdiivseea sem. an1a5g-e26m,e ntAu g,o f 0as evere preeclampsia ANTIHISTAMINES Biodcahye mipactaile nt macrarkee.r s 35-o4f6 ,b onNeo v,r emoao deling Sep, 0a 80-105, May, oa Interstitial cystitis—a urogynecologic perspective Legacy of Roe v Wade: protecting women’s health Epidural accident. 167, Jul, mu 119-130, Jun, 0a BIOPHYSICS through legal abortion. 33-44, May, oa Gynecologic examination of the prepubertal girl. 71- Antepartum fetal monitoring: when, what, and how Talking about sex: an interview with Gloria Feldt 90, Jul, oa ANTIOXIDANTS 36-45, Sep, 0a 52-58, apr, oa Humane approach to neonatal circumcision. 135- Sperm-function tests. 87-108, Sep, oa ABiGsEp hFosApChToOnRatSe s for treating and preventing osteo- Lap1a4r5o,s cJoupny, 0dau ring pregnancy: a safe alternative to ANTIVIRALS BBeInOiPgSnY breast disorders: first rule out cancer. 154- porosis. 105-120, Apr, oa laparotomy? 75-91, Apr 15, oa New therapies for genital condyloma in women. 81- 172, Mar, 0a Fertility over 35: Improving the odds. 106-118 Mississippi operative vaginal delivery trial: Lessons 36, Feb, 0a Current management of endometrial cancer. 85-99, May, sy learned. 60-79, Oct, oa Dec, oa Identifying women with inherited risk for ovarian My approach to surgical correction of total uterovagi- APPENDICITIS Hepatitis C, D, and E in pregnancy. 29-38, Jun, oa cancer: who and why? 27-50, Dec, oa nal prolapse. 72-87, Jan, oa Laparoscopy during pregnancy: a safe alternative to Interstitial cystitis—a urogynecologic perspective Prenatal diagnosis with fetal cells enriched from Of epidurals and patient equality. 10-13, Oct, ed laparotomy? 75-91, Apr 15, oa 119-130, Jun, 0a maternal blood: Will the promise be fulfilled? Percutaneous abscess drainage in gynecology. 66- Missed appendicitis. 135, Dec, mu Menometrorrhagia and a polypoid uterine mass 178-188, Sep, oa 74, Apr, 0a Diagnosis: High-grade endometrial stromal sarco- Surgical management of dysgerminoma. 98-119, Performing saline infusion sonography. 110-122, ARTHRITIS ma. 70-81, Nov, pq TaFke1ib0n,0g- o1aa2 9,r esOucltt,s -ooar iented approach to infertility PerSfeoprm,i cndg vacuum-assisted vaginal delivery. 61-67, Autoimmune disease. 13-31, Jan, 0a PerSfeopr, micndg saline infusion sonography. 110-122 Testing for genetic susceptibility to ovarian and Nov, cd ASPHYXIA Role of reassessment laparoscopy in managing ovar- breast cancer. 88-114, Mar, oa What's new with female sterilization: an update. 91- Ob, the certified nurse-midwife, and the $9 million ian cancer. 101-111, Aug, oa Twenty-five years of cesarean delivery. 87-97 117, Jun, oa award. 171-172, Aug, mu Surgical management of dysgerminoma. 98-119 May 15, 0a What's new with male sterilization: an update. 41- Feb, oa What's new with female sterilization: an update 67, Jul, oa ASPIRIN 91-117, Jun, 0a Immunology of early pregnancy loss. 40-56, Jun, 0a BIRTHWEIGHT ANEUPLOIDY Mississippi operative vaginal delivery trial: Lessons AIDS: see HUMAN IMMUNODEFICIENCY VIRUS Echogenic intracardiac focus. 73-78, Jun, 0a ASSISTED REPRODUCTIVE TECHNOLOGY learned. 60-79, Oct, oa ALCOHOL DRINKING Fetal echogenic bowel: the bottom line. 53-69 Fertility over 35: Improving the odds. 106-118 China: land of contrast, land of change. 36-46, Dec, oa May, sy BISPHOSPHONATES Aug, 0a Klinefelter's syndrome: an update. 142-158, Aug, oa Bisphosphonates for treating and preventing osteo- ANOVULATION Prematurity in multifetal pregnancy: can we reduce porosis. 105-120, Apr, oa ALENDRONATE Phytoestrogens: fact or fiction. 49-66, Sep, oa the risk? 112-140, Aug, sy Seven steps to the effective treatment of osteoporo- Bisphosphonates for treating and preventing osteo- Sperm-function tests. 87-108, Sep, oa sis in your practice. 30-50, Feb, oa porosis. 105-120, Apr, oa ANTIBIOTICS Surgical management of dysgerminoma. 98-119 Sevseins isn tyeopusr tpor atchtei cee.f fe3c0ti-v5e0 , trFeeabt,m eonat of osteoporo- AAnctuitbei otriecs piursaet orfyo r dipsrtervesesn tisnygn drpormeet.e rm2 5-b3i3rt,h . No2v6,- 302a, TakFienbg, ao ar esults-oriented approach to infertility. 100- BmLpAacDtD ERof female pelvic anatomy on stress urinary ALTERNATIVE MEDICINE May, 0a 129, Oct, oa ncontinence. 45-59, Oct, oa LNoawu-steeac ha nadp pvroomiatcihn g.t o 1l3o-w1-6b,a ckM aypa,i n.o a 80-98, Oct, oa GGrBoSu pu pdBa tes:t reap tporcoogcrceasls irnefpeocrtt.i ons7 1-8in5 , preDgenc,a ncsyy. 21- Tenm anyiepaurlsa tioofn . las1e2r6--a1s5s0i,s teSde p, gaoam ete and embryo 119-1i3a0l , cyJsutn,i tiosa— a urogynecologic perspective One kind of medicine or many? The view from NIH 26, Oct, oa Then and now—the explosion of reproductive My approach to surgical correction of total uterovagi- 123-145, Feb, cd Gynecologic examination of the prepubertal girl. 71- options. 47-59, May 15, oa nal prolapse. 72-87, Jan, 02 Perimenopause: easing the transition. 93-114, 90, Jul, 0a Jul, 0a Lyme disease in pregnancy. 31-39, Jul, 0a AUTOIMMUNE DISEASES BLOOD COAGULATION FACTORS Phytoestrogens: fact or fiction. 49-66, Sep, oa My approach to surgical correction of total uterovagi- Autoimmune disease. 13-31, Jan, 0a Brain blood ciot cause of death 148-151, Jan, mu AAcMtiEvNe ORwoRmHanE:A special health concerns. 131-140, Ophntahl alpmroilaa psnee.o na7t2o-r8u7,m . Ja2n,5 -2o8a, Feb, oa AWARDS AND PRIZES EmeArugg,e ncmuy C/S results in $175,000 award. 171 Oct, 0a Percutaneous abscess drainage in gynecology. 66- Contemporary OB/GYN 10th Annual Author Awards Caring for the breast cancer survivor. 37-56, 74, Apr, 0a 164, Aug, 0a BLOOD PRESSURE May, 0a Postpartum endometritis. 33-38, Jan, oa Conservative management of severe preeclampsia Preventing and managing incisional surgical site BACK PAIN 80-105, May, oa AMNIOCENTESIS infections. 69-85, Sep, oa Low-tech approach to low-back pain. 80-98, Oct, oa Conservative management of severe preeclampsia Preventing GBS transmission to neonates. 53-69, BLOOD TRANSFUSION 80-105, May, oa Mar, sy BACTEREMIA Acute respiratory distress syndrome. 25-33, Nov, 0a Firdsetn-cter.i me1s2t8er- 13a8m,n iJoucle, ntoea sis: weighing the evi- Puerperal mastitis. 27-33, Apr, 0a Pyelonephritis in pregnancy. 31-42, Mar, 0a Hepatitis C, D, and E in pregnancy. 29-38, Jun, oa Genetic amniocentesis. 16-24, Apr, oa Pyelonephritis in pregnancy. 31-42, Mar, oa Genetic revolution. 99-104, May 15, oa Sperm-function tests. 87-108, Sep, 0a BACTERIA BODY TEMPERATURE Ultrasound in obstetrics and gynecology: an imaging Techniques for isolating pelvic bacterial pathogens Techniques for isolating pelvic bacterial pathogens Preventing and managing incisional surgical site revolution. 67-84, May 15, oa 49-56, Nov, 0a 49-56, Nov, 0a infections. 69-85, Sep, oa 108 CONTEMPORARY OB/GYN # DECEMBER 1998 For more information, circle 124 on RSVP card. > = EDITORIAL INDEX—IDENTIFICATION CODES bb— Back to Basics ed— Editorial oa— Original Article Special issues: cd— Clinical Dialogue et— Equal Time pq— Pathology Quiz April 15—— Technology co— Controversies in Ob/Gyn mu— Malpractice sy— Symposium May 15— 25th Anniversary Issue BONE AND BONES CALCIUM CELL CYCLE CHLAMYDIA INFECTIONS Biochemical markers of bone remodeling in day-to- Bisphosphonates for treating and preventing osteo Cell cycle. 117-126, Jul, bb ithalmia vatorum. 2! day patient care. 35-46, Nov, 0a porosis. 105-120, Apr, oa Mitosis, meiosis, and nondisjunction. 47-51 ndometritis. 3 Bisphosphonates for treating and preventing osteo Caring for the breast cancer survivor 37-56 Mar, bb porosis. 105-120, Apr, oa May, 0a CHOLESTEROL New generation of bone densitometers. 15-40 Myth of calcium. 173-174, Mar, et CENTRAL NERVOUS SYSTEM Phytoestrogens: fact or fiction. 49-66, Sep, oa Apr 15, oa Myth of calcium. Author's reply. 174, Mar, et Ultrasound fetal survey. 15-28, Jul, oa Sexuality after menopause. 138-159, Apr, sy Osteoporosis: Assessment, diagnosis, treatment, Perimenopause: easing the transition. 93-114 CHORIONIC VILLUS SAMPLING and prevention. 4-26, Apr (suppi), sy Jul, 0a CEPHALOSPORINS First-irimester amniocentesis: weighing the ev Seven steps to the effective treatment of osteoporo Seven steps to the effective treatment of osteoporo GBS update: a progress report. 71-85, Dec, sy e. 128-138, Jul, oa sis in your practice. 30-50, Feb, oa sis in your practice. 30-50, Feb, 0a Preventing and aging incisional surgical sit can we reduce Sexuality after menopause. 138-159, Apr, sy infections. 69-85, Sep, oa Treatment options for recurrent endometriosis CANCER Pyelonephritis in pregnancy. 31-42, Mar, oa 34-41, Oct, oa Cervical cancer not diagnosed. 148, Jan, mu Cervical neoplasia: past, present, and future. 117 CERCLAGE BONE MARROW TRANSPLANTATION 132, May 15, oa Prematurity in multifetal pregnancy: can we reduce CIRCUMCISION Stem cells: What the obstetrician needs to know ERT for endometrial cancer survivors? 160-164, the risk? 112-140, Aug, sy e@ approach to neonatal circ 141-155, Jul, oa Apr, oa >, JUN, 0a European tobacco ‘smoke screen’. 12-15, Apr, ed CEREBRAL PALSY BONE MINERAL DENSITY Genetic revolution. 99-104, May 15, oa Lack of fetal movement. 151, Jan, mu CLINDAMYCIN Biochemical markers of bone remodeling in day-to- Menometrorrhagia and a polypoid uterine mass tpartum e day patient care. 35-46, Nov, 0a Diagnosis: High-grade endometrial stromal sarco- CERTIFICATION Bisphosphonates for treating and preventing osteo- ma. 70-81, Nov, pq Contemporary OB/GYN: \ooking back and looking porosis. 105-120, Apr, oa New therapies for genital condyloma in women. 81 forward. 10-12, May 15, ed 96, Feb, oa c oncology. 125 BORIC ACID Percutaneous abscess drainage in gynecology. 66- Vaginitis 1998: Update and guidelines. 116-132, 74, Apr, 0a Jan, cd Progress in gynecologic oncology 125-146 CERVICAL CANCER May 15, oa Cervical neoplasia: past, presen BREAST Screening your patients for inherited breast and 132, May 15, 0a Benign breast disorders: first rule out cancer. 154- ovarian cancer: how to collect family history data Controversies in the managem 172, Mar, 0a 107-132, Nov, 0a cal cancer 100, Apr, oa Syncope. 15-25, Jun, 0a Progress in BBBerRenE1a1iAs74gt29nS ,, T c bMFaraenCebrcaA,,es Nrt m CoauEd p iRast oirednetr s:f ailfsi rstto rruelte uronu t focra nceevra.l uat1i5o4n- UWTsheeasb 7ttr1i’eo-nsaf8g s 7 t,un lfetcowrMar aa nsrcgo,ew neriint.c0he a t 8ims8cua- rl1ge1si 4uc,sas lct eeprMaitalsirip,bzi iartlaioiotatni :yo n taoin n ougvpyadnraeitaceno. loga4yn1 d- CPrEeRmtMV,hae Iy X r i1s5k,? oa1 12-140, Aa ug, sy CCCeOOrLvM1i3PPc2aO,Ul ST CMEnaODeyPo pYlT1a 5sO,i Ma:O0 aG RpaAstP,H Yp:r esesnete, TOanMdO GfRutAuPreH Y, Caring for the breast cancer survivor. 37-56 67, Jul, 0a X-RAY COMPUTED May, 0a CESAREAN SECTION Delayed diagnosis. 167, Jul, mu CANCER STAGING B-Lynch suture for control COMPUTERS Doctor refuses to order 3-month follow-up mammo- Advanced ovarian cancer: recent progress and cur hemorrhage. 93-98, Aug, cd h equipment for operative laparoscopy. 43-52 gram. 146, Feb, mu rent challenges. 123-137, Apr, 0a Emergency C/S results in $1 ERISA can’t shield HMO from breast cancer suit Controversies in the management of stage 1B cervi- Aug, mu pstetrics and gynecology 175, Apr, mu cal cancer. 77-100, Apr, oa GBS update: a progress report. 71 ERT for endometrial cancer survivors? 160-164, Current management of endometrial cancer. 85 Group B streptococcal infecti GonAaapndrdo, t ar0noat paignon-irsetlse).a sin82g- 95h,o rmNoovn, e 0aa nalogs (agonists SuDFreegibcc,,a l ooaa m anagement of dysgerminoma. 98-119 29-35, Aug, 0a 31-88 CONDOscMenSts ’ risk sition: developmental Identifying women with inherited risk for ovarian Misc1sa5en6cde- r1:5b 9r,ewa hsotO c ta,c nadmn ucwe rh y?d i2a7g-n5o0s,i s Delce,a dosa to lawsuit CVaAgNiJnDainIt,Di sIc Ad S1I9S98 : Update and guidelines. 116- No lOeRar naedv.a ila60b-l79e, fo(r ces irds6 4 an-d9 1, thAeu g,b ees0:a talking to teens Patimeenntt . co1m8p5e, nsMaatri, onm u fund liable for additional pay- CARDIOVASCULAR DISEASE Plendteayt h.o f b1l2a4-m1e2 7,to gMoa y, marouu cecs,e ntiunrcyr easoifn g c succesasc.e pti1o3n-:2 8, reMmaayr k1a5,b loea PPSehcyrrotieaome eensnitonrpgoag uesnyeso::u r fepaacastt iinoegrn tfsit chteifo on.rt rain4ns9ih-tei6ro6in,t. edS 9e3pb-,r 1e1oa4as, t aJnuld CCaarrdMiianaygc, d0fiaos re asteh.e 1b5r-e2a6s,t Acuag,n ceora survivor. 37-56 PPRroeesctmtohapreta drur irtisut$kmy1? 6 .e1in5n1 d 2om-mume1lit4tlr0ilif,iteo itnsa A.lu ga,wp< raersgydn anciyn : cascea n ofw er uprteudurceed ClewO NDtYhLerOapMiAesT Af or AgCeUniMtaIlN AcToAnd yloma in women. 81- Teso1tv0ia7nr-gi1 a3n2 f,orc angNceoenvr,e: t i0cha ows ustoc ecpotlilbeiclti tfya mitloy ohviasrtoirayn daatnad CFrAaRgrRieltIeaE rRdXa t iSsoTynnA dTrEaon mde : pream actourmem onm enocpaausues e. of 4me7n-t7a0l TThw evue tne$try5u-s0f,0i ,ve0C 0/P0.y eanr1es7e 5d,l oef. A pcre,1s 7a2rm,e ua nAu g,d elmivue ry. 87-97, May NTIALITY al aspiration breast cancer. 88-114, Mar, 0a Jan, 0a nagement of rape in adolescents. 62-78 Understanding why women wonit take HRT. 133- Hepatitis B vaccination for adolescents. 153-161 141, Jan, oa Sep, 0a CHEMOTHERAPY examination o e prepubertal girl Was 3-week delay fatal in Pennsylvania breast Ca Advanced ovarian cancer: recent progress and cur BPBuRReEEcraApEseSCerTH?a-l F1P8EmR0aEs,Et DiSItMEiNasNr.G ,T A2mT7uI- 3O3N, Apr, 0a CIPPneeAtrreT17rcfHs14uot9E,tri-t TamA1iniEa3penl0Rr og,I,u cZs0yaA sJs aTutlanIiib,ntO seiNc ose a—si ans f usudirrooangi nyansgeoecn oolgiorng aipghcyy n.e cpoelro1sgp1ye0.c- t1i2v62e6 - CCCuaornrrMcrDtieaaeernlncyno gt,,tv c eacrnoh0fmscaaaoaie rlren l.sae tnghgeeie nm s7e7 tb-nhr1et0e 0 a,ms atof nA paerg,n edomomaee nttr ialof sctanacgeer . 1B 85-99 CCeOrNt hI3rZ2co,yA u TgoShIMtf oa O yN Rlo ege15 a 1l5 , v aob0noaW ratdpieoan:s. t, p3rp3ro-et4se4ec,ntt i,n gMa ya,nw do moeaf nut’usre . he1a1l7t h Twenty-five years of cesarean delivery. 87-97 Sep, cd Progress in gynecologic oncology 125-146 CONJUNCTIVITIS May 15, 0a Performing vacuum-assisted vaginal delivery. 61-67 May 15, oa Ophthalmia neonatorum. 25-28, Feb, oa Nov, cd Role of reassessment laparoscopy in managing ovar CALCITONIN Pubic bone suburethral stabilization sling: a long ian cancer. 101-111, Aug, oa CONTRACEPTION Bisphosphonates for treating and preventing .osteo- term cure for SUI? 52-76, Feb, oa Surgical management of dysgerminoma. 98-119 ond the birds and the bees: talking to teens porosis. 105-120, Apr, oa Feb, oa it sex. 35-64, Apr, oa Seven steps to the effective treatment of osteoporo- CEFTRIAXONE Use of ultrasonic surgical aspiration in gynecology for the breast cancer survivor. 37-56 sis in your practice. 30-50, Feb, oa Pyelonephritis in pregnancy. 31-42, Mar, 0a 71-87, Mar, 0a oa DECEMBER 1998 = CONTEMPORARY OB/GYN 111 EDITORIAL INDEX—IDENTIFICATION CODES bb— Back to Basics ed— Editorial Original Article Special issues: cd— Clinical Dialogue et— Equal Time Pathology Quiz April 15— Technology co— Controversies in Ob/Gyn mu— Malpractice Symposium May 15— 25th Anniversary Issue Sexuality after menopause. 138-1 59, Apr, sy Was planned VBAC delivery to blame for stillbirth? Testing for genetic susceptibility to ovarian and Taking a results-oriente approach to infertility. 100 182, Mar, mu breast cancer. 88-114, Mar, 0a 129, Oct, oa What's the standard of care? 127, May, mu Three patients sue for condyloma misdiagnosis Talking about sex: an interview with Gloria Feldt. 52- Woman sent home after membranes rupture. 146- 138-141, Nov, mu 58, apr, oa 149, Feb, mu Trichomoniasis. 23-35, Sep, 0a Testing for genetic susceptibilit y to ovarian and Vaginitis 1998: Update and guidelines. 116-132, breast cancer. 88-114, Mar, oa DENSITOMETRY Jan, cd Emerger y Understanding why women wonit take HRT. 133- New generation of bone densitometers. 15-40 Feb. et 141, Jan, 0a Apr 15, 0a DIAGNOSTIC TESTS Legacy of Roe v What's with female sterilization: an update. 91 Active woman: special health concerns. 131-140, 117, Jun, 0a DEOXYRIBONUCLEIC ACID Oct, oa What's new with male sterilization: an update. 41 Cell cycle. 117-126, Jul, bb Biochemical markers of bone remodeling in day-to- 67, Jul, 0a Cervical neoplasia: past, present, and future day patient care. 35-46, Nov, 0a t remarkable 132, May 15, 0a Cardiac dised 26, Aug, 0a 3-28, May 0a CRYOPRESERVATION Fragile X syndrome: a common cause of nta Colorectal cancer screening: why it belongs in gyne- Zation: af Stem cells: What the obstetrician needs to know retardation and premature menopause 47- 70 cologic practice. 49-76, Aug, oa 141-155, Jul, 0a Jan, 0a Current management of endometrial ca er. 85-99, Ten years of laser-assisted gan te and embryo Genetic revolution. 99-104, May 15, oa ec, 0a CONTRACEPTIVE SEES manipulati 26-150, Sep, oa vaaeiieae 41-45, Jan, bb Immunology of early pregnancy loss. 40-56, Jun, 0a Quarter century of Then and AONe e —_ osion of reproductive Mitosis, meiosis, and nondisjunction. 47-51, Mar Interstitial cystitis—a urogynecologic perspective advance 47 bb 119-130, Jun, oa Testing for genetic susceptibility to ovarian and Low-tech approach to low-back pain. 80-98, Oct, oa CONTRACEPTIVES, ORAL CRYOTHERAPY breast cancer. 88-114, Mar, oa Perimenopause: easing the transition. 93-114, Cervical tli present, and future. 117 DEPRESSION PreJnuait, al0 a diagnosis with fetal cells enriched from Date rape: office-based solutions. 133-153, Mar, 0a maternal blood Will the promise be fulfilled? 178 Low-tech approach to low-back pain. 80-98, Oct, oa 188, Sep, oa shied FIBROSIS One kind of medicine or many? The view from NIH Screening your atients for inherited breast and hogenic bowel the bottom line. 53-69 123-145, Feb, cd ovarian cancer: how to collect family history data >, 0a Perimenopause ing the transitic 107-132, Nov, 0a oreast and Jul, oa psis syndromes. 13-16, Dec, oa story data CYSTITIS Sexuality after menopause. 138-159, Apr, sy even steps to the effective treatment of osteoporo- Interstitial cystitis—a urogynecologic perspective sis in your practice. 30-50, Feb, oa 411109.-112300 , J | DIABETES MELLITUS Syncope. 15 Jun, oa and Antepartum fetal monitoring: when, what and how Taking a results-oriented approach to infertility. 100 CYSTOSCOPY 36-45, Sep, 0a 129, Oct, oa Interstitial cystitis—a urogynecologic perspectiv syndrome: an update. 142-158, Aug, 0a Ultrasound in obstetrics and gynecology an imaging 119 Newborn's blood sugar nut tested. 151, Jan, mu revolution. 67-84, May 15 66-74, Apr CYTOMEGALOVIRUSES DIAGNOSIS, LABORATORY DIET Fetal echogenic bowel: the bottom line 53-69 Amniotic fluid indices of maturity. 15-20, Sep, oa a gn breast disorders: first rule out cancer cOosT ee Dec, 0a Autoimmune disease. 13-31, Jan, oa 72, Mar, 0a Managed car Bisphosphonates for treating and preventing osteo veh of calcium. 173-174, Mar, et Prematurit 2 reduce DANAZOL Cervpoircoasli s. neo1p0l5as-i1a2:0 , paAsptr,, porae sent, and future. 117- MNyatuhs eaof canadl civuomm itiang.i thor1’3s- 16r,ep ly.M ay,17 4,o a Mar, et Negligent prescriofpD taniocorinne . 147, Jan, mu 132, May 15, oa One kind of medicine or many? The view from NIH Conservative management of severe preeclampsia 123-145, Feb, cd DELIVERY 80-105, May, oa Colorectal can in ayne- Amniotic fluid embolus. 204, Sep, mu Controversies in the management of stage 1 B cervi DIURETICS Is mcoeltoghioct f ectopic ABaubtyo idmrmoupnpeed didsureiansge .e m1 e13r-g3e1,n cy Jadne,l iv0ear y. 147, Jan, mu Fetacall ncuacnhcearl. fo7l7d- 1t0r0a,n slAupcr,e ncoya screening. 117-131, ABceuntieg n rebsrpeiarsatt ordyi sodridsetrrse:s s fsiyrnstd rroumlee. ou2t 5-c3a3n,ce r.N ov,1 5o4a B-Lynch suture for control of massive postpartum Mar, 0a 172, Mar, oa heme rencala9p3 -98, Aug, cd Fragile X syndrome: a common cause of mental retar Renal disease. 13-21, Nov, oa COUNSELING e. 15-26, Aug, oa dation and premature menopause. 47-70, Jan, oa Adolescents develop won defen se. 203, Sep, mu GBS update: a progress report. 71-85, Dec, sy DNA: see DEOXYRIBONUCLEIC ACID Co! china: land of contrast, land of change. 36-46 Group B streptococcal infections in pregnancy alking to teens Aug, 0a 21-26, Oct, oa Conservative management of severe preeclampsia Gynecologic examination of the prepubertal girl DOWN SYNDROME yreventing osteo 80-105, May, oa 71-90, Jul, 0a Echogenic intracardiac focus. 73-78, Jun, 0a Did prolonged rupture of membranes cause child's Hepatitis C, D, and E in pregnancy. 29-38, Jun, oa Fetal echogenic bowel: the bottom line. 53-69 Lyme disease in pregnancy. 31-39, Jul, oa Dec, oa Menometrorrhagia and a polypoid uterine mass Fetal nuchal fold translucency screening 17-131 case settled. 151, Jan, mu Diagnosis: High-grade endometrial stromal sar Mar, oa Sippi operative vaginal delivery coma. 70-81, Nov, pq Genetic revolution. 99-104, May 15, oa learned. 60-79, Oct, 0a Mother of stillborn infant blames biood bank's oa Notification rules in Florida 185, Mar, mu reporting delay. 149, Feb, mu DRUG EFFECTS Mar, 0a Ob, the ified nurse-midwife, and the $9 million Nausea and vomiting. 13-16, May, oa Antibiotic use for preventing preterm birth. 26-32 53-69 award. 171-172, Aug, mu Ophthalmia neonatorum. 25-28, Feb, oa May, 0a Performing vacuum-assisted vaginal delivery. 61-67 Postpartum endometritis. 33-38, Jan, oa Better loving through chemistry? 8-11, Jun, ed of mentnt ai Nov, cd Preventing GBS transmission to neonates. 53-69 Bisphosphonates for treating and preventing osteo- 47-70 Postpartum endometritis. 33-38, Jan, oa Mar, sy porosis. 105-120, Apr, oa Prematurity in multifetal pregnancy: can we reduce Puerperal mastitis. 27-33, Apr, 0a Gonadotropin-releasing hormone analogs (agonists Ss. 40-56, Jun, oa the risk? 112-140, Aug, sy Pyelonephritis in pregnancy. 31-42, Mar, 0a and antagonists). 82-95, Nov, 0a Preventing GBS transmission to neonates. 53-69 Renal disease. 13-21, Nov, 0a Nausea and vomiting. 13-16, May, oa Mar, sy Routine antenatal laboratory tests and specific New therapies for genital condyloma in women. 81- Prolapsed cord. 164-167, Jul, mu screening tests. 15-22, Feb, oa 96, Feb, oa Prolonged use of vacuum leads to settlement. 138 Sperm-function tests. 87-108, Sep, oa Sexuality after menopause. 138-159, Apr, sy Nov, mu Surgical management of dysgerminoma. 98-119 Syncope. 15-25, Jun, oa Shoulder dystocia cases. 1 68-171, Aug, mu Feb, oa Thirteen-day trial on postop pain medication. 204 Twenty-five years a cesa rean delivery. 87-97, Techniques for isolating pelvic bacterial pathogens Sep, mu May 15, oa 49-56, Nov, oa Trichomoniasis. 23-35, Sep, oa 112 CONTEMPORARY OB/GYN = DECEMBER 1998 EDITORIAL INDEX—IDENTIFICATION CODES bb— Back to Basics ed— Editorial oa— Original Article Special issues: cd— Clinical Dialogue et— Equal Time pa— Pathology Quiz April 15— Technology co— Controversies in Ob/Gyn mu— Malpractice sy— Symposium May 15— 25th Anniversary Issue DRUG RESISTANCE Screening your patients for inherited breast and ESTROGENS FETAL HEART GBS update: a progress report. 71-85, Dec, sy ovarian cancer: how to collect family history data Bisphosphonates for treating and preventing osteo- Antepartum fetal monitoring: when, what, and how Pyelonephritis in pregnancy. 31-42, Mar, oa 107-132, Nov, 0a porosis. 105-120, Apr, 0a 36-45, Sep, 0a Vaginitis 1998: Update and guidelines. 116-132, Understanding why women won't take HRT. 133- Current clinical uses of low-dose estrogen therapy. Echogenic intracardiac focus. 73-78, Jun, 0a Jan, cd 141, Jan, oa 4-26, May (suppl), sy Four-chamber view; expectations and limitations. ERT for endometrial cancer survivors? 160-164 89-112, Jan, oa DABuiRstUppooGhri oomssTmipsuH.hn EoeRn 1aA0tdP5eiY-ss1e 2as0fe,o. r tA1rp3era,-t 3io1na,g Jaann,d 0par eventing osteo- EWhLaE9t1C'-sT1 R17On,Ce wO JAuGnw,iU tLho Aa TfIemOaNl e sterilization: an update FFoorrAteephwwreoor,ra rdpd:0y :a. C3u,Nr arMteunatry a lc( lsiunppiprcla)ol,g eusestdee sr oonfe :l ow-Mdeosceh aensitsrmogse,n ITUnwlfetan1rn5tat,y s -obfu0oianr vdne wfeiytteahal r shs yurpovofepy l.ca esst1ai5rc- e2al8ne, ft dhJeuellai,rv te.or ay .1 358,7 -D9e7c,, Mmauy Conservative management of severe preeclampsia effects, and safety. 3, Sep (suppl), ed 80-105, May, oa ELECTROSURGERY Gonadotropin-releasing hormone analogs (agonists FETAL MONITORING Fragile X syndrome: a common cause of mental Cervical neoplasia: past, present, and future. 117- and antagonists). 82-95, Nov, oa Antepartum fetal monitoring: when, what, and how retardation and premature menopause. 47-70 132, May 15, oa Impact of female pelvic anatomy on stress urinary 36-45, Sep, oa Jan, 0a Electrosurgery leads to burn during cervical biopsy incontinence. 45-59, Oct, oa Cardiac disease. 15-26, Aug, 0a Immunology of early pregnancy loss. 40-56, Jun, 0a 146, Feb, mu Perimenopause: easing the transition. 93-114, Contemporary OB/GYN: \ooking back and lcoking Interstitial cystitis—a urogynecologic perspective Jul, 0a forward. 10-12, May 15, ed 119-130, Jun, 0a EMBRYO Phytoestrogens: fact or fiction. 49-66, Sep, oa Failure to timely perform nonstress test blamed for Low-tech approach to low-back pain. 80-98, Oct, oa Genetic revolution. 99-104, May 15, oa Quarter century of contraception: remarkable child's brain damage. 141, Nov, mu New therapies for genital condyloma in women. 81- Ten years of laser-assisted gamete and embryo advances, increasing success. 13-28, May 15, oa Genetic amniocentesis. 16-24, Apr, 0a 96, Feb, oa manipulation. 126-150, Sep, oa Immunology of early pregnancy loss. 40-56, Jun, 0a Sepsis syndromes. 13-16, Dec, oa ETHICS, MEDICAL Renal disease. 13-21, Nov, oa STeavksieinnsg isna t eyropeussr u ltpotr sa-tchoteri cieee.nf tfee3dc 0ti-va5ep0 p,r torFaeeacbth,m eotnoat inofefr toilsittye.o po1r0o0-- ESTywMneEcnoRtpGye-E.f NiCv1Ie5 E-2Sy5 e, arJsu n,o f0 ac esarean delivery. 87-97, Theonpt ioanns.d 4n7o-5w9—,t hMea y e1x5,p l0oas ion of reproductive Ultrreavsooluuntdio n.i n 6o7b-st8e4t,r icMsa ya nd15 ,g yonae cology: an imaging TVrage4i1a1n2t,i9 mt,ei Onsc tOtc ,t1 ,9oo 9pao8t a:i onsU pdfoart er ecaunrdr engtu ideenldionmeest.r ios1i1s6.- 13324,- ENDMaOyM E1T5R, IoAa L CANCER ECToHnfIotCrewSma,rp do.Pr aRrO1y0F -E1S2O,BS /IGMOYaNNyA: L1 5\,o oekdi ng back and looking FAnEtT3eA8pL-a 4r5tM,u OmVS eEpfMe,t Eal0N a Tmo nitoring: when, what, and how. Jan, cd CarMianyg, 0fao r the breast cancer survivor. 37-56, Managed care and ethics. 162-176, Sep, sy FETAL ORGAN MATURITY DYSGERMINOMA Current management of endometrial cancer. 85-99 ETHNIC GROUPS Amniotic fluid indices of maturity. 15-20, Sep, oa SurFgiecba,l0 am anagement of dysgerminoma. 98-119 $8D0een0cd,,o 0mo0eat0 r ials etCta.l em1e4n1-t1 42f,o r Ndoevl,a ym u in diagnosing DIadtecneat nircfaeyprie:n: g wofwhfooi mceaen-ndb aswewhdiyt h?s ol2iu7nt-hi5eo0rn,is t.e dD 1e3cr,3i -s1ko a5 3f,or Moavra,r iaona FCoEnTsUeSr vative management of severe preeclampsia. DMSTihwYsoeSsluneiTltasOdrysenCi-repIfd pi.Ai dv yes6 ot0po-eyc7rei9aaa,t r iscv aOesc oetsf,v. a ocgaie1 ns6aal8r -e1da7en1l ,iv edrAeylu igv,ter riayml.:u L8e7s-s9on7s, EGMRoeTnnAaa pondrdmfo, oet rtaro nroate poanirgdnoron-hmiraseetgtlsrie)ia.aa s li n8a2gnc- da9 5nh,cao e rrpmN ooolvns,yeu p rooviaiad vn oarlusot?ge rsi n1e(6 a0g-om1nai6ss4st s SWchrao1t1ev10’ea7s7nr, -ii a1nnn3Jge u2 wn,c , ay nowNc0uioeatrrv h :, pfaoehatm oiaewln et tso s tcefrooilrll iezciatnt ihoefnra:i mtieladyn hbuiprsdetaoatrseyt. daa9tna1d.- FLPeeytrmaD8fele0o c-r,1dme 0iic50snha,ego a gsMvee aanycii,ucn u pmor-abe aogswnesalin:sc yt.e dth e3v 1a-bg3io9nt,at lo Jmud le,l ilvioneaer .y . 5631--6697,, May 15, oa Diagnosis: High-grade endometrial stromal sar- Nov, cd coma. 70-81, Nov, pq Syncope. 15-25, Jun, oa EATING DISORDERS Progress in gynecologic oncology 125-146, EXERCISE Active woman: special health concerns. 131-140, May 15, oa Active woman: special health concerns. 131-140 FEVER Oct, 0a Oct, 0a Percutaneous abscess drainage in gynecology. 66- 74, Apr, 0a ENDOMETRIOSIS EDUCATION, MEDICAL Genetic revolution. 99-104, May 15, 0a EXERCISE THERAPY Preventing GBS transmission to neonates. 53-69, CurrDeecn,t omaa nagement of endometrial cancer. 85-99, Intleorgcye. ed9 6-u1s0e 2,a ndNo v,a dhoeas ion prevention in gyneco- Low-tech approach to low-back pain. 80-98, Oct, oa PueMrapre,r als y mastitis. 27-33, Apr, oa Gonadotropin-releasing hormone analogs (agonists Then and now—the explosion of reproductive FALLOPIAN TUBES Legaancdy anotfa gRoonies tsv) . Wad8e2-:9 5p,r oNtoevc,t in0ga women’s health Treoapttmieonnst. 4op7t-i5o9n,s Mfaory r1e5c,u rroae nt endometriosis. 34 Intleorgcye. ed9 6-u1s0e 2,a ndNo v,a dhoeas ion prevention in gyneco- FBeInBiRgOnC YbSreTaIsCt dDiIsSorEdAeSrsE:, fBirRstE ArSulTe out cancer. 154- through legal abortion. 33-44, May, oa 41, Oct, 0a Then and now—the explosion of reproductive 172, Mar, 0a Ob-gyn in the year 2025. 8-11, Mar, ed options. 47-59, May 15, oa OOnn e1 t3h,ke i nSfder po,no tf edmli endeis,c inine obor- gymna nya?nd Tohne tvhiee wY anfgrtozme . NI8H- EPeNrDfOorMmEiTngR IUsaMl ine infusion sonography. 110-122 What11'7s, nJeunw, woiat h female sterilization: an update. 91- FSeLpUsIiDs TsyHnEdRrAomPeYs . 13-16, Dec, oa 123-145, Feb, cd Sep, cd Preventing and managing incisional surgical site Perimenopause: easing the transition. 93-114 FETAL BLOOD FLUOROURACIL infections. 69-85, Sep, oa Jul, 0a Prenatal diagnosis with fetal cells enriched from New therapies for genital condyloma in women. 81- Progress in gynecologic oncology. 125-146, May Postpartum endometritis. 33-38, Jan, oa maternal blood: Will the promise be fulfilled? 178- 96, Feb, oa 15, 0a Techniques for isolating pelvic bacterial pathogens 188, Sep, oa Use of ultrasonic surgical aspiration in gynecology. Screening your patients for inherited breast and 49-56, Nov, oa 71-87, Mar, 0a ovarian cancer: how to collect family history data FETAL BLOOD SAMPLING 107-132, Nov, oa EPIDEMIOLOGY Stem cells: What the obstetrician needs to know FOLLICLE-STIMULATING HORMONE UK medical training bottleneck. 8-10, May, ed Colorectal cancer screening: why it belongs in gyne- 141-155, Jul, 0a Fertility over 35: Improving the odds. 106-118, cologic practice. 49-76, Aug, oa May, sy EDUCATION, PATIENT FETAL DEATH Phytoestrogens: fact or fiction. 49-66, Sep, oa ACCCDHdloaeaiolptrnclMocMaeiioreoata cnnelsiyaygscorlct,,ia t gie pdaisneelmc0 f0:tr aoa asar B’nptc or iaaafotnvgcfnhacrteiseiciecms. ccrke eei -.bnn borsa7tafcet9s 4 rai-e9eSso9de-oTnt1 nf7 D ,i 6 s nr,ofgca laAo:apucr uenAtq gi uuc,oaiwgen ids,hrnsio0 .y tla ai oe odassnio 1ctu:l e3 rebnv3seti-cldvs1eooe.n5nr vt3.ges, sl. 1 o5pi3Mm3na67 e-r2-gn1,-5yt 67n6a18eo,l,,a- EEMEAOinpPpRtsihIislYsMtbSeiiaThiasIoyorasHt,tnOlioRei pTmdcmOp0i.O yia aM M uYYb6so nCle0pe a-Ieom7rNfne9aoa ,dtrt i ovprOferuco ertm ,v.v ie annogctaio2 inn5nat-lgi 2 n8ed,pne rcleeiFtv.eeeb ,rr ym1 408at,rb ii arlt:Jh .a nL, e2s6ms-uo3 n2s, CDNMMUhieiinisgssrnAtllss1eaureii8ic:aegsg0n ors,s,egngs i n e nptdl0Mfip .aaaeoiz ntrfa ead ,nld 6 sol0 apw-omhteefe7fuerear9 tar,iacttf lnoie gntvrd atOeialcr s tstatee,svr dr teavess,oigatsc airt.ei n h.pa. l l a1 nr411d1u2d3, le40 el,,odi f Nv oMeDgvrcaer,yhcy o,a,u n mtngrumimdea uul.s: fL3oer6s -ss4ou6ni,ts FMPFieSOsrHRlsNf:eioCo asvrErs,smnPi eeipeSdcnp .d gi F O6voL0ap-cLe7ruI9auC,tm Li-vEaOe-sc tsS,ivT asI0gtaiMe nUda Ll AvaTdgeIilNniavGle rydH elOtirRvieaMrl:yO . NLeE6s1 s-o6n7s, Sep, oa Managed care and ethics. 162-176, Sep, sy ESTRADIOL FETAL GROWTH RETARDATION GAMETE INTRAFALLOPIAN TRANSFER One kind of medicine or many? The view from NIH Fertility over 35: Improving the odds. 106-118, Fetal echogenic bowel: the bottom line. 53-69, Then and now—the explosion of reproductive 123-145, Feb, cd May, sy Dec, 0a options. 47-59, May 15, oa DECEMBER 1998 = CONTEMPORARY OB/GYN 115 EDITORIAL INDEX—IDENTIFICATION CODES bb— Back to Basics ed— Editorial Original Article Special issues: cd— Clinical Dialogue et— Equal Time Pathology Quiz April 15— Technology co— Controversies in Ob/Gyn mu— Malpractice Symposium May 15— 25th Anniversary Issue COUNSELING Preventing GBS transmission to neonates. 53-69, Foreword: Mood, cognition, and dementia: Effects My approach to surgical correction of total uterovagi- nt S for inherited breast and Mar, sy of postmenopausal hormone therapy. 3, Feb nal prolapse. 72-87, Jan, 0a ollect family history data Treatment options for recurrent endometriosis. 34- (suppl), ed Progress in gynecologic oncology. 125-146, 41, Oct, 0a Foreword: Postmenopausal hormone therapy May 15, 0a Ultrasound fetal survey. 15-28, Jul, oa Treatment choices for medical conditions. 3, Nov Treatment options for recurrent endometriosis Ultrasound in obstetrics and gynecology: an imaging (suppl), ed 34-41, Oct, oa revolution. 67-84, May 15, oa Identifying women with inherited risk for ovarian why it belongs in gyne Vaginitis 1998: Update and guidelines. 116-132 cancer: who and why? 27-50, Dec, oa HYSTEROSALPINGOGRAPHY Jan, cd Mood, cognition, and dementia: Effects of Taking a results-oriented approach to infertility. 100- postmenopausal hormone therapy. 4-24, Feb 129, Oct, oa n cause of mental HEALTH BEHAVIOR (suppl), sy nopause. 47-70 Human potential: a global perspective. 10-13, Jul, Perimenopause: easing the transition. 93-114, IMMUNE SYSTEM ed Jul, 0a Stem cells: What the obstetrician needs to know China: land of contrast, land of change. 36-46, Aug, Phytoestrogens: fact or fiction. 49-66, Sep, oa 141-155, Jul, 0a 0a Postmenopausal hormone therapy: Treatment choic- ted risk for ovarian Human potential: a global perspective. 10-13, Jul es for medical conditions. 4-26, Nov (suppl), sy IMMUNIZATION c 0, Dec, 0a ed Seven steps to the effective treatment of osteoporo- Hepatitis B vaccination for adolescents. 153-161, Karyotypes. 41- Managed care and ethics. 162-176, Sep, sy sis in your practice. 30-50, Feb, oa Sep, 0a Klinefe 142-158, Aug, 0a One kind of medicine or many? The view from NIH Sexuality after menopause. 138-159, Apr, sy Hepatitis C, D, and E in pregnancy. 29-38, Jun, oa Mitosis unction. 47-51 123-145, Feb, cd Treatment options for recurrent endometriosis. 34- Immunology of early pregnancy loss. 40-56, Jun, 0a Mar, bb Telemedicine comes to obstetrics and gynecology 41, Oct, oa Prenata enriched from 97-111, Apr 15, 0a Understanding why women won't take HRT. 133- IMMUNOGLOBULINS materr ise be fulfilled? 178- 141, Jan, 0a Immunology of early pregnancy loss. 40-56, Jun, 0a HEMATOLOGIC DISEASES Stem cells: What the obstetrician needs to know HORMONES IMPLANTS, CONTRACEPTIVE breast can 141-155, Jul, oa Fertility over 35: Improving the odds. 106-118, May, Quarter century of contraception: remarkable Then and n sy advances, increasing success. 13-28, May 15, oa options. 4 HEMORRHAGE Gonadotropin-releasing hormone analogs (agonists B-Lynch suture for control of massive postpartum and antagonists). 82-95, Nov, oa IN VITRO FERTILIZATION GESTATION, MULTIPLE hemorrhage. 93-98, Aug, cd Interstitial cystitis—a urogynecologic perspective Contemporary OB/GYN: \ooking back and looking Antepartum fetal monitoring: when, what, and how What's new with female sterilization: an update. 91- 119-130, Jun, oa forward. 10-12, May 15, ed 117, Jun, 0a Klinefelter's syndrome: an update. 142-158, Aug, oa Fertility over 35: Improving the odds. 106-118, More is better, but for wh 1, Jan, ed Nausea and vomiting. 13-16, May, oa May, sy Prematurity in mu cy: can we reduce HEPARIN Managed care and ethics. 162-176, Sep, sy Immunology of early pregnancy loss. 40-56, Jun, oa HPV: see PAPILLOMAVIRUSES More is better, but for whom? 8-11, Jan, ed WroOncgtf, ulm u pregnancy as < Inte1rs1t9i-t1ia3l0 , cyJsutni, tiosa— a urogynecologic perspective HRT: see HORMONE REPLACEMENT THERAPY STpakeirnmg- fuan cretsiuolnt s-toerstise.n te8d7 -1a0p8p,r oaScehp , too ai nfertility. 100- AnGACFFteosEitensrSa83sMdpsel6T0aeeta s-r-Arn-4rs,1vtcn5 Ttm0,arueIe 5 tic 0,nOhima taev Nls eA t MLeoaSeeff p ty,1 o a lglAde 0¢ : G Etr maorn slucen cy scrweee2i€8nwg, ih hnapitMgr,an e rge, calntoadham e p sheiovawi - PHHHIHeoenEEppfsPaRaSeet1AttecNmp1piiTt4eaI,tti,Irr iioA Tgstsu o I isuMa nmSCa Bg , yd ieDvns,pa1de ac5oaatc,msnieh edtn0os raag i tEetin iioinssnn . opabrfn-3eodg3rg n-ya3naan8 d c,ocyf lh.rea Josnamcnge 2,in9 nt-1gs039a. 87 ,3f oc1Jutu5son.3 ,- 119016a901 78 - HICRWnhoUofaunMefes16tttco1m7cA'irt4e,erswni,N mera oee pgrJu nduisoMnl.iI nre,a ang Mawnygd 0 rMt i1ayes0Up t1wn e-e5aNias,a1ttt Ots2Ohsha,e .DB0o l s/aEgm GeMFa1Ynal5iIlNsne-ya C: 2 b I2ooa1s,bErt5n -\ea,Ndgro tF iCyoeolenkYbiard,zi y anc tgfihVo roaatIno en:Rbm sg aUticSsnak1 gn 9 a7an3fund opdc du atstos.el p .oe1 oc9k1ii90f4n78i1g- c- TTIACenhoNtnenFiom1M 8snAbpa2a0e tinN9yy-rioi,T,eo1vtp a ,ania0unsrc Otl50.d scai,a Lt tv ,uiOe 4soon MW7efnoao- .aym5 wl,Bf9aa— o,Insr1t o aeR2ahrgMpT6 -erea-Hae1ym Wsv5 eseE0nine1I,sttx5 Gti,p enHlSgdooTeo apsf ,ipg osraenoevma t eeertorefem rpbraeienrptderh. co ldeaum2mc6pbt-sri3iyv2aoe, FGeonu8er9t--ic1c1 h2aa,mm nbie Jran , v0i ew ec2t4a,t ioApnrs, 0aan d limitations My naalp pprrooalcaphs e.t o s7u2r-g8i7c,a l Jcano,r re0cat ion of total uterovagi- HStYeDmR OcPelSl s: FEWThAaLtI St he obstetrician needs to know. Laplaarpoasrcootpoym y?d ur7i5n-g9 1,p reAgpnra nc1y5:, oaa safe alternative to LPergetmahacrtyou urgiottf Ri etAalu 1g. ,p p3rr3oeS-tgy4e n4ca,tn icnygM: a yw,c oamonea n’wes rheedaulcteh HInEfRee1c1Pmt4eEi,r oSguVisMI nagRyd U iSsp1e 5aa,t sIheoNosagF eEniCns T IoaObn-NdgS y na cfhraonmg in1g9 73f ocutso. 1919078- HNaYuP1s4Ee1Ra- E1M5a5nE,dS IvJSoum li,t GionRag A. VI1D3-A1R6,U MM ay, oa IGGNrBoFS2uA 6pN,u Tp,dOBca tt,esN :tE roWeaap B tpOorcRoogNcrc easl s irnefpeocrtt.i ons7 1-i8n5 ,p reDgenca,n csyy. 21- GIFT: see GAMETE INTRAFALLOPIAN TRANSFER Ophthalmia neonatorum. 25-28, Feb, oa HYPERINSULINEMIA Hepatitis C, D, and E in pregnancy. 29-38, Jun, oa Twenty-five years of cesarean delivery. 87-97 Hyperinsulinemia causes seizures. 172, Apr, mu Humane approach to neonatal circumcision. 135- GLOMERULONEPHRITIS May 15, oa 145, Jun, oa Autoimmune disease. 13-31 HYPERTENSION Ophthalmia neonatorum. 25-28, Feb, oa HIRSUTISM Antepartum fetal monitoring: when, what, and how Preventing GBS transmission to neonates. 53-69, GONADOTROPINS Sexuality after menopause. 138-159, Apr, sy 36-45, Sep, oa Mar, sy Fertility over 35: Improving the odds. 106-118, Autoimmune disease. 13-31, Jan, oa May, sy HOME CARE SERVICES Renal disease. 13-21, Nov, 0a INFECTION Gonadotropin-rele 1ormone analogs (agonists Telemedicine comes to obstetrics and gynecology Acute respiratory distress syndrome. 25-33, Nov, oa and antagonists). Nov, 0a 97-111, Apr 15,0 a HYPOXEMIA Adolescents’ risk of STD acquisition: developmental Is methotrexate | first-line therapy for ectopic Antepartum fetal monitoring: when, what, and how considerations. 79-91, Aug, 0a pregnancy -160, Oct, co HOMOSEXUALITY 36-45, Sep, 0a Antibiotic use for preventing preterm birth. 26-32, Klinefelter's syndrome: an update. 142-158, Aug, oa Beyond the birds and the bees: talking to teens May, oa Then and now—the explosion of reproductive about sex. 35-64, Apr, oa HYSTERECTOMY Benign breast disorders: first rule out cancer. 154- options. 47-59, May 15, oa Advanced ovarian cancer: recent progress and cur- 172, Mar, oa Treatment options for recurrent endometriosis. 34- HORMONE REPLACEMENT THERAPY rent challenges. 123-137, Apr, oa Clinical management of rape in adolescents. 62-78, 41, Oct, oa Active woman: special health concerns. 131-140, Controversies in the management of stage 1B cervi- May, 0a Oct, oa cal cancer. 77-100, Apr, oa Fetal echogenic bowel: the bottom line. 53-69, GUIDELINES Benign breast disorders: first rule out cancer. 154- Current management of endometrial cancer. 85-99, Dec, oa Colorectal cancer screening: why it belongs in gyne- 172, Mar, oa Dec, oa Group B streptococcal infections in pregnancy. 21- cologic practice. 49-76, Aug, oa Bisphosphonates for treating and preventing osteo- ERT for endometrial cancer survivors? 160-164, 26, Oct, oa Fetal nuchal fold translucency screening. 117-131, porosis. 105-120, Apr, oa Apr, 0a Gynecologic examination of the prepubertal girl. 71- Mar, 0a Caring for the breast cancer survivor. 37-56, LAVH causes brain damage. 203-204, Sep, mu 90, Jul, oa Low-tech approach to low-back pain. 80-98, Oct, oa May, 0a Menometrorrhagia and a polypoid uterine mass. Hepatitis B vaccination for adolescents. 153-161, Mississippi operative vaginal delivery trial: Lessons ERT for endometrial cancer survivors? 160-164, Diagnosis: High-grade endometrial stromal sarco- Sep, 0a learned. 60-79, Oct, 0a Apr, 0a ma. 70-81, Nov, pq Hepatitis C, D, and E in pregnancy. 29-38, Jun, 0a 116 CONTEMPORARY OB/GYN # DECEMBER 1998 panne EDITORIAL INDEX—IDENTIFICATION CODES bb— Back to Basics ed— Editorial oa— Original Article Special issues: cd— Clinical Dialogue et— Equal Time pq— Pathology Quiz April 15— Technology co— Controversies in Ob/Gyn mu— Malpractice sy— Symposium May 15— 25th Anniversary Issue nfectious diseases in ob-gyn from 1973 to 1998 INSURANCE, LIABILITY LAPAROTOMY First-trimester amniocentesis: weighing the evi- emerging pathogens and a changing focus. 107- Contemporary OB/GYN: \ooxing back and looking Is methotrexate optimal first-line therapy for ectopic dence. 128-138, Jul, oa 114, May 15, 0a forward. 10-12, May 15, ed pregnancy? 142-160, Oct, co nformed consent: Is videotape viewing sufficient? LUPUS ERYTHEMATOSUS, SYSTEMIC 182-185, Mar, mu INTERFERON LASERS Antepartum fetal monitoring: when, what, and how nterceed use and adhesion prevention in gynecolo- HepatitisC , D, andE in pregnancy. 29-38, Jun, 0a Ten years of laser-assisted gamete and embryo 36-45, Sep, oa gy. 96-102, Nov, oa New therapies for genital condyloma in women manipulation. 126-150, Sep, oa Autoimmune disease. 13-31, Jan, 0a Laparoscopy during pregnancy: a safe alternative to 81-96, Feb, oa laparotomy? 75-91, Apr 15, oa LAWSUITS LUTEINIZING HORMONE Missed abortion. 171, Apr, et INTERNET Amniotic fluid embolus. 204, Sep, mu Gonadotropin-releasing hormone analogs (agonists Ophthalmia neonatorum. 25-28, Feb, oa Telemedicine comes to obstetrics and gynecology Baby born with spina bifida. 149, Jun, mu and antagonists). 82-95, Nov, oa Postlaparoscopy peritonitis is patient's responsibility 97-111, Apr 15, 0a Brain blood clot cause of death. 148-151, Jan, mu 172, Aug, mu Breast cancer patient fails to return for evaluation LYME DISEASE Postpartum endometritis. 33-38, Jan, 0a INTRAUTERINE DEVICES 149, Feb, mu Infectious diseases in ob-gyn from 1973 to 1998 Puerperal mastitis. 27-33, Apr, oa Infectious diseases in ob-gyn from 1973 to 1998 Causation defense. 203, Sep, mu emerging pathogens and a changing focus. 107 Pyelonephritis in pregnancy. 31-42, Mar, oa emerging pathogens and a changing focus. 107 Cervical cancer not diagnosed. 148, Jan, mu 114, May 15, oa Role of reassessment laparoscopy in managing ovar- 114, May 15, oa Did prolonged rupture of membranes cause child’s Lyme disease in pregnancy. 31-39, Jul, oa ian cancer. 101-111, Aug, oa Quarter century of contraception: remarkable colds? 159, Oct, mu Routine antenatal laboratory tests and specific advances, increasing success. 13-28, May 15, 0a Episiotomy blamed for incontinence. 148, Jan, mu LYMPH NODES screening tests. 15-22, Feb, oa Ultrasound in obstetrics and gynecology: an imaging Failure to diagnose twin-to-twin transfusion and the Advanced ovarian cancer: recent progress and cur Sepsis syndromes. 13-16, Dec, 0a revolution. 67-84, May 15, 0a HMO. 172, Aug, mu rent challenges. 123-137, Apr, oa Stem cells: What the obstetrician needs to know. In defense of the Balfour. 149, Jun, mu Caring for the breast cancer survivor. 37-56 141-155, Jul, 0a 1ODINE Informed consent. 146-149, Jun, mu May, 0a Sutures in gynecologic surgery. 57-72, Apr 15, oa Informed consent: Is videotape viewing sufficient? Controversies in the management of stage 1B cervi- Techniques for isolating pelvic bacterial pathogens Ophthalmia neonatorum. 25-28, Feb, oa 182-185, Mar, mu cal cancer. 77-100, Apr, 0a 49-56, Nov, oa Notification rules in Florida. 185, Mar, mu Current management of endometrial cancer. 85-99, Toxoplasmosis in pregnancy. 21-24, Dec, oa KARYOTYPING Physician strikes back. 164, Jul, mu Dec, oa Trichomoniasis. 23-35, Sep, oa Karyotypes. 41-45, Jan, bb Postlaparoscopy peritonitis is patient's responsibility Role of reassessment laparoscopy in managing ovar- Vaginitis 1998: Update and guidelines. 116-132 172, Aug, mu ia ncer. 101-111, Aug, oa Jan, cd KIDNEY DISEASES Shoulder dystocia cases. 168-171, Aug, mu Surgical management of dysgerminoma. 98-119 What's new with female sterilization: an update. 91- Autoimmune disease. 13-31, Jan, oa Thirteen-day trial on postop pain medication. 204 Feb, oa 117, Jun, oa Renal disease. 13-21, Nov, 0a Sep, mu Three patients sue for condyloma misdiagnosis MAGNESIUM SULFATE IFKSSTelNpuarireFktnMFgri1Eieeailn2mfRbyci9eg-,Tta,l, fyItl u ae LonsOr Iaco'ycrm tTvs te, aeYsi rnu os loanyatn g3 sd5e-tr:oem osremtiseneI.:n mt tp e8rd7ao on-vf 1ai 0upnd8ppgyd,r as otgaetSec.her ehpm , i1otn4dooo2 dams- i.na1f .5er 8ti,1l i0t9y6A8.u --g11,11 108900, -a KALMciNAtsEBiOslEvceiOeta sR, rs n IiewpN0dopaJ.mi U aRn6Io:0pE -e7Sr9 a,st pievcOeic at,l v a0ghaie naallt h decloinvceeryr nst.r ial: 13L1e-s1s4o0n,s TUWWWishrameaosMg1i t1n aa3n8'gtor82gsif,fp-, o u l1n ls.4aitm e sM1nh uca,enrepu 1e,vcr4ds ele6t ri,Ngamyp onnVtvsuad,h BF n aieAcbrinCn,ymdg uf maoaidiunfsel leciidaanv freenterruey?tbi w al ilt1t o2yc 7 al,bius gulsaieaMtt mi aoyepno, l f e apfa.mor cruot vi1soo8tkni0?el- slb1 i18r5lt2i6ht i? - CMLNMooeAAnwwG8ALs- 0peNtP-rreER1gv cT0aAeh15Itn5C ,,ieC Tvra eIa0p MatpCR ariEEymoo ,aSan c nOh0aN aog Afte Nom bCeloEonn wte- bIaMdocfeAk nG ssIeipNvatieGonr.m e e t8ep0rr-se9.e8 c,l a1Omc5pt,-s i4a0o a Ten years of laser-assisted gamete and embryo LABOR, PREMATURE Oct, mu Baby dropped during emergency delivery. 147 TTihmemoinpant ngii opanunsils.da teiv4one7nr-o.y5 wt9h,—i 1tn2ghM6 ea-1 iyn5 0ie1,n5xf ,ep rlStoioelaspi t,iy o nosa u ito f plreae.p ro1d8u0c-t1i8v2e APnrcteuiMmtbaaeiyt ou,trri eics0 tpayi ursaetin o rfymo url dtiipsfrteertveaesl sn tpisrnyegng dnraponrmceyet:.e rm2 c5a-nb3i 3rt,wh .e No2rv6e,-d u3co2ae LLeEgGtaIhcrSyoL uAgoThf I OlReNog ea l va boWratdieon:. p3r3o-t4e4ct,i ngM ay,w om0ea n’s health BDierftm1ehu4 n8 sc,eo n tJrabona,l s epmdi ull so n anuds uaolb esictuys tocma usea nde mpbroalctiiscme. 200 Mar, mu Pyetlhoen eprihsrki?t is1 12i-n 1p4r0e,g naAnucgy,. sy3 1-42, Mar, 0a LENGTH OF STAY DelSaeype,d mdui agnosis. 167, Jul, mu Vaginitis 1998: Update and guidelines. 116-132 Managed care and ethics. 162-176, Sep, sy Distress of late fetal death ruled grounds for suit INFORMATION SERVICES Jan, cd Preventing GBS transmission to neonates. 53-69 180, Mar, mu One kind of medicine or many? The view from NIH Mar, sy Doctor refuses to order 3-month follow-up mammo- 123-145, Feb, cd LAPAROSCOPY Role of reassessment laparoscopy in managing ovar gram. 146, Feb, mu Telemedicine comes to obstetrics and gynecology Advanced ovarian cancer: recent progress and cur- ian cancer. 101-111, Aug, oa Ectopic pregnancy missed. 124, May, mu 97-111, Apr 15, 0a rent challenges. 123-137, Apr, oa $800,000 settlement for delay in diagnosing Beyond ‘band aid’ surgery. 12, Apr 15, ed LEUKOCYTES endometrial Ca. 141-142, Nov, mu INFORMED CONSENT Is methotrexate optimal first-line therapy for ectopic Immunology of early pregnancy loss. 40-56, Jun, 0a Electrosurgery leads to burn during cervical biopsy IIIMTnmneaffsmno1otuar8ringm2mnoe-eegld1 ddo 8 g5fcy,occor a on rnseosegM fenea ntnaret.ena,: rtd l imyc1e u4 It ps6h ir-scve1usi4gs. d9nce,eao pn1ttc6iay2Jbpu -ine1,l l7 io6stv,smy.i u e wS4tioe0n p-g,5o 6v,ass ryu ifJfauinnc ,i eanonta?d LLLaaAppVpnlaaHirarrq epuoogaecss.nracc oauootnspp6ocei1ymsy-c y ?7 ?1 db, urs 1rau74iti52unnJ-r -ug9in1 d,n16 ag,p0:m r, oae aAgg pneaOra. c n tfc,1ay 5s2:,t0 c 3oo a-aan2 d0 4sa,fe ea sSyae lpt,ne renmwau t itvee ch-t o LFMeEyrUt MniaPaallypRi ,tpO pyr rLoosIaolycDav pheEsr e .t o3 5s:7u 2r-g8Ii7mc,ap lr oJcvanoi,rn rge ocat itohne oofd dtso.t al 1ut0e6r-o1va1g8i EEEErpRmbiIe'dA1Srsuu4A r6gg, ,aep lan clcFmasaenuyycb’ c,t ic daCems/snuehSt i. e slredet1 st6lu7elH,dt .Ms OJu 1li,5n 1 f,r $mou1mJ 7 a5n,b, r0e0ma0us t acwaanrdc.e r 1s7u1it breast cancer. 88-114, Mar, oa Negl15i9g,e ntOlcyt, pmeur formed laparoscopy causes death LIBIDO Fail1u7r5e, tAop rt,i mmeuly perform nonstress test blamed for New equipment for operative laparoscopy. 43-52 Sexuality after menopause. 138-159, Apr, sy child's brain damage. 141, Nov, mu INFUSIONS Apr 15, oa Foreign body under uterus. 151, Jan, mu Performing saline infusion sonography. 110-122 Postlaparoscopy peritonitis is patient's responsibility LICENSURE Hyperinsulinemia causes seizures. 172, Apr, mu Sep, cd 172, Aug, mu One kind of medicine or many? The view from NIH Infant born with hypoplastic left heart. 135, Dec, mu Role of reassessment laparoscopy in managing ovar- 123-145, Feb, cd Insurer needn't pay the piper for sexually deviant ILaNpSaUrFoFsLcoApTyI ONdu ring pregnancy: a safe alternative to Takiianng caan creers.u lt1s-0o1r-i1e1n1t,e d Aaupg,p rooaac h to infertility. 100- Tel9e7m-e1d1i1,c ineA prc o1m5,e s0 a to obstetrics and gynecology Lacdko c.o f f1e8t2a,l mMaorv,e memnut . 151, Jan, mu laparotomy? 75-91, Apr 15, oa The1n2 9, anOdc t, nooaw —the explosion of reproductive LIVER DISEASE LMAisVsHe dc aaupspeesn dibcriatiins . da1m3a5g,e . Dec2, 03-m2u0 4, Sep, mu options. 47-59, May 15, oa HepatitisC , D, anEdi n pregnancy. 29-38, Jun, oa Missed breast cancer diagnosis leads to lawsuit INSURANCE, HEALTH Treatment options for recurrent endometriosis. 34- Hepatitis B vaccination for adolescents. 153-161 156-159, Oct, mu Managed care and ethics. 162-176, Sep, sy 41, Oct, oa Sep, 0a Missing fetal heart rate strip. 130, Dec, mu Of epidurals and patient equality. 10-13, Oct, ed Use of ultrasonic surgical aspiration in gynecology Mother of stillborn infant blames blood bank’s Redlining comes to managed care. 8-11, Nov, ed 71-87, Mar, 0a LUNG reporting delay. 149, Feb, mu Testing for genetic susceptibility to ovarian and What's new with female sterilization: an update. 91- Acute respiratory distress syndrome. 25-33, Nov, 0a Negligent answering service. 124, May, mu breast cancer. 88-114, Mar, oa 117, Jun, oa Amniotic fluid indices of maturity. 15-20, Sep, oa Negligent prescription of Danocrine. 147, Jan, mu 118 CONTEMPORARY OB/GYN # DECEMBER 1998 For more information, circle 126 on RSVP card. >